Inactive Instrument
Epigenomics AG Stock Xetra
Stocks
DE000A1K0516
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Xetra
|
||
| - EUR | - |
|
| 09-03 | Epigenomics AG Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-02 | Epigenomics AG Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 798K 898K 745K 679K 1.28M 86.35M 1.29M 9.01M 3.49M 44.14M 3.37M 3.3M 142M | P/E 2024 |
-0.29x | P/E 2025 | -2.51x |
|---|---|---|---|---|---|
| Enterprise Value | 11.77M 13.24M 10.98M 10.01M 18.88M 1.27B 19.05M 133M 51.49M 651M 49.72M 48.64M 2.09B | EV / Sales 2024 |
-
| EV / Sales 2025 | 490x |
| Free-Float |
70.75% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
| Corporate Officer/Principal | 55 | 2024-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Helge Lubenow
CHM | Chairman | 58 | 2023-02-28 |
Alexander Link
BRD | Director/Board Member | 55 | 2020-05-31 |
Jochen Hummel
BRD | Director/Board Member | 56 | 2024-02-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| +1.20% | -2.27% | +21.42% | +80.97% | 57.39B | |
| +1.61% | -1.40% | +3.37% | +37.18% | 47.64B | |
| +0.36% | +0.81% | +342.39% | +748.97% | 44.29B | |
| -0.96% | -4.50% | +24.96% | +31.45% | 42.5B | |
| -0.20% | -0.77% | +4.13% | +111.69% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +54.06% | 30.97B | |
| +1.56% | +3.75% | +31.90% | +29.14% | 28.53B | |
| +0.05% | -1.64% | -8.14% | -12.10% | 24.34B | |
| Average | +0.84% | -0.59% | +53.19% | +130.61% | 43.39B | |
| Weighted average by Cap. | +1.18% | -0.84% | +57.47% | +139.99% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 24K 27.01K 22.4K 20.42K 38.51K 2.6M 38.86K 271K 105K 1.33M 101K 99.21K 4.26M |
| Net income | -3.35M -3.77M -3.13M -2.85M -5.38M -363M -5.43M -37.86M -14.67M -185M -14.16M -13.86M -595M | -314K -353K -293K -267K -504K -33.97M -508K -3.55M -1.37M -17.37M -1.33M -1.3M -55.74M |
| Net Debt | 10.46M 11.77M 9.76M 8.89M 16.77M 1.13B 16.93M 118M 45.76M 578M 44.18M 43.22M 1.86B | 10.97M 12.34M 10.24M 9.33M 17.6M 1.19B 17.76M 124M 48M 607M 46.34M 45.34M 1.95B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
